Under the agreement, Dr Reddy's will have exclusive rights from SHIPL to promote and distribute Beyfortus within the country ...

Dr. Reddy's Laboratories Ltd. closed 17.18% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant Sanofi’s Indian ...

The company plans to introduce Beyfortus, which contains the monoclonal antibody, nirsevimab, in a prefilled injection used ...

The company plans to introduce Beyfortus, which contains the monoclonal antibody nirsevimab, in a prefilled injection used ...

Uncertainties around US tariffs and the end of the limited competition period for generic Revlimid in the US will loom in ...

Dr. Reddy’s Laboratories will expand its partnership with Sanofi Healthcare India (SHIPL) by launching the latter’s novel drug Beyfortus (nirsevimab) in India.

Shares of Bajaj Finance, Bajaj Finserv, Trent, Ambuja, BPCL, and NTPC Green are likely to be in the focus as these companies ...

Dr. Reddy’s is one of the largest generic drug manufacturers in the world. Global generics make up over 85% of the firm's sales, and along with other generics manufacturers, it continues to ...

Hyderabad gastroenterologist D. Nageshwar Reddy awarded Padma Vibhushan for medical contributions by President Murmu.

VIJAYAWADA: Former Defence Research and Development Organisation (DRDO) Chairman Dr G Satish Reddy officially assumed charge ...